A phase IB, open-label, dose-escalating study of vatalanib in combination with capecitabine in patients with advanced cancer.
Phase of Trial: Phase I
Latest Information Update: 26 Sep 2009
At a glance
- Drugs Capecitabine; Vatalanib
- Indications Cancer; Colorectal cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Novartis
- 26 Jun 2008 Status changed from in progress to completed, according to ClincalTrials.gov
- 03 Feb 2006 New trial record.